Latest News
Select the category
Preliminary Results for the Year Ended 30 April 2025
Notice of Results
Director Dealing
Director Dealing
Scancell reports Phase 2 data showing strongly improved outcomes in Late-Stage Melanoma with its Immunobody® iSCIB1+
Share Option Exercise
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.